New drug combo could tame autoimmune hepatitis and cut steroid use
NCT ID NCT06381453
First seen Feb 28, 2026 · Last updated May 19, 2026 · Updated 7 times
Summary
This study tests whether adding belimumab to standard treatment can better control autoimmune hepatitis, a chronic liver disease where the immune system attacks the liver. About 48 adults with active or well-controlled disease will receive weekly belimumab injections for 72 weeks. The goal is to reduce liver inflammation and lower the need for steroids and other immune-suppressing drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE HEPATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
G.I Research Institute
RECRUITINGVancouver, British Columbia, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
McMaster University
RECRUITINGHamilton, Ontario, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Toronto General Hospital
RECRUITINGToronto, Ontario, M5G 2C4, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Calgary
RECRUITINGCalgary, Alberta, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.